Low-level laser therapy (LLLT) as a possible resource to attenuate muscle damage in delayed onset muscle soreness (DOMS)

  • Natalia Camargo Rodrigues Iosimuta*
  • , Salvador Ramos*
  • , Paul Ohsem
  • , Aderson Loureiro
  • , Ro Nogueira
  • , Andrew Bulmer
  • , ACM Renno
  • , Roberta Renshaw
  • , E-Liisa Laakso
  • *Corresponding author for this work

Research output: Contribution to conferencePaperResearch

Abstract

The aim of this study was to investigate if the infrared laser irradiation can prevent or minimize delayed onset muscle soreness (DOMS). Eight healthy male were divided in two groups: laser group and sham laser group. All volunteers were submitted to an Eccentric Exercise Protocol (EEP) for biceps brachii to induce muscle damage. Active laser (780 nm; 50 mW; 500 mW/cm 2 ; 12 J/cm 2 ; energy of 5 J per point applied for 20 s on four points) or sham were applied two times, before and after EEP. Maximal voluntary contraction, range of motion, muscle soreness, creatine kinase activity, lactate, C-reactive problem, IL-6, IL-8, Ferric Reducing Capacity of Plasma and total bilirubin were analyzed before, 8, 24, 48, 72, 120 and 168 h after EEP. LLLT decreased IL-6 levels after 8 h of eccentric exercise in laser group. No significant differences were observed in other systemic markers of inflammation, antioxidant status or in muscle performance between groups. The results suggest a partial attenuation of muscle damage, as laser therapy was able to reduce IL-6 levels.
Original languageEnglish
Pages45-54
Number of pages10
Publication statusPublished - 2014
Externally publishedYes
EventWALT biennial Congress and NAALT Annual Conference - Renaissance Arlington Capital View hotel, United States
Duration: 9 Sept 201412 Sept 2014
https://waltpbm.org/event/walt-2014-biannual-congress/

Conference

ConferenceWALT biennial Congress and NAALT Annual Conference
Country/TerritoryUnited States
Period9/09/1412/09/14
Internet address

Fingerprint

Dive into the research topics of 'Low-level laser therapy (LLLT) as a possible resource to attenuate muscle damage in delayed onset muscle soreness (DOMS)'. Together they form a unique fingerprint.

Cite this